The store will not work correctly when cookies are disabled.
6-((2-chloro-10H-phenothiazin-10-yl)methyl)-1,3,5-triazine-2,4-diamine
ID: ALA1099319
PubChem CID: 46888180
Max Phase: Preclinical
Molecular Formula: C16H13ClN6S
Molecular Weight: 356.84
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(N)nc(CN2c3ccccc3Sc3ccc(Cl)cc32)n1
Standard InChI: InChI=1S/C16H13ClN6S/c17-9-5-6-13-11(7-9)23(10-3-1-2-4-12(10)24-13)8-14-20-15(18)22-16(19)21-14/h1-7H,8H2,(H4,18,19,20,21,22)
Standard InChI Key: QEXQZWNRCYXEBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
12.1065 0.0418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1053 -0.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8220 -1.2018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5404 -0.7873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5375 0.0454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8202 0.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3885 -1.2009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8178 1.2830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2575 -1.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9732 -0.7850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4052 0.0356 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.9684 0.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6872 0.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6910 1.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9768 1.6887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2575 1.2744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2571 0.4505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4022 -0.7920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6888 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6864 -2.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3966 -2.4329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1107 -2.0200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1097 -1.2014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3955 -3.2601 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18 11 1 0
11 13 1 0
5 6 2 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
2 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
6 8 1 0
16 17 2 0
17 12 1 0
4 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 2 0
10 19 1 0
21 22 1 0
2 3 1 0
22 23 2 0
23 18 1 0
10 12 1 0
21 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.84 | Molecular Weight (Monoisotopic): 356.0611 | AlogP: 3.49 | #Rotatable Bonds: 2 |
Polar Surface Area: 93.95 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.69 | CX LogP: 4.13 | CX LogD: 4.13 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.73 | Np Likeness Score: -1.56 |
References
1. Bag S, Tawari NR, Degani MS, Queener SF.. (2010) Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens., 18 (9): [PMID:20363634] [10.1016/j.bmc.2010.03.031] |